Heart Failure (Part 2) - 31/08/11
Abstract |
The treatment for heart failure (HF) caused by systolic dysfunction (heart failure with reduced ejection fraction, HFREF) is currently better defined than that of HF caused by diastolic dysfunction (heart failure with preserved ejection fraction, HFPEF). Available drugs include blockers of the renin-angiotensin-aldosterone system (i.e. angiotensin-converting enzyme inhibitors, angiotensin II AT-1 receptor blockers, aldosterone antagonists, direct renin inhibitors), beta blockers, diuretics, nitrate derivatives and digoxin. When HF stage III-IV with left ventricular ejection fraction less than 35% and QRS complexes greater 120ms persist despite optimal medical therapy, cardiac resynchronization therapy (CRT) yields a benefit in the majority of cases, both in terms of quality of life and reduction in mortality.
Le texte complet de cet article est disponible en PDF.Keywords : Renin-angiotensin-aldosterone system inhibitors, Beta-blockers, Diuretics, Nitrate derivatives, Digoxin, Cardiac resynchronization therapy (CRT)
Plan
 | Copyright 2010, Éditions Médecine et Hygiène, 46, ch. de la Mousse, CH-1225 Chêne-Bourg. |
Vol 2 - N° 4
P. 237-244 - septembre 2011 Retour au numéro
Article précédent
- Systematic and narrative review of treatment for older people with substance problems
- I. Moy, P. Crome, I. Crome, M. Fisher
- Reversible delirium in an elderly patient due to intracranial dural arteriovenous fistula with retrograde leptomeningeal venous flow
- D.J. Cordato, S.R. Taneja, M.A. Davies, C. Dedousis, P. Smerdely, J. Kuan, A. Goh, W. Clark
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?